Chinese PLA General Hosptial

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Neuroendocrine tumours1 trial
• Pancreatic cancer1 trial
• Psoriasis1 trial

Phase

• Phase 21 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Chinese PLA General Hospital1 trial
• CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1 trial
• Shenzhen Salubris Pharmaceuticals Co., Ltd.1 trial

Running trials

• Active, not recruiting

  Machine Learning-Based Prediction of Insulin Resistance in Psoriasis Patients Emphasizing Interpretability

  NCT07321288· Chinese PLA General Hospital· Source

• Not yet recruiting

  Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD Patients

  NCT07079579· Phase 4· Shenzhen Salubris Pharmaceuticals Co., Ltd.· Source

  Contact: Xiangmei Chen, MD.&Ph.D

• Recruiting

  A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)

  NCT06505395· Phase 2· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.· Source

  Contact: Jianming Xu, M.D

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Neuroendocrine tumours1 recruiting
• Pancreatic cancer1 recruiting